Extracorporeal photopheresis for systemic sclerosis: A meta‐analysis of randomized clinical trials
C Delbrück, T Gambichler, L Susok… - Dermatologic …, 2022 - Wiley Online Library
Abstract Systemic sclerosis (scleroderma)(SSc) is a rare autoimmune disorder characterized
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …
by excessive production of collagen. Extracorporeal photopheresis (photochemotherapy …
The assessment of immune-regulatory effects of extracorporeal photopheresis in systemic sclerosis: a long-term follow-up study
The therapeutic options in systemic sclerosis (SSc) are limited mainly to the management of
complications, and decelerating fibrosis and preventing disease progression are still great …
complications, and decelerating fibrosis and preventing disease progression are still great …
Use of extracorporeal photopheresis in scleroderma: a review
AX Du, M Osman, R Gniadecki - Dermatology, 2020 - karger.com
Background: Scleroderma is a heterogeneous group of diseases that can be localized or
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
systemic. Localized scleroderma is a fibrosis of the skin characterized by inflammation and …
Preliminary results on long-term follow-up of systemic sclerosis patients under extracorporeal photopheresis
T Gambichler, O Özsoy, D Bui, CH Scheel… - Journal of …, 2022 - Taylor & Francis
Background Extracorporeal photopheresis (ECP) has been considered for treatment of
patients with systemic sclerosis (SSc). Objectives To study the 12-month effects of ECP on …
patients with systemic sclerosis (SSc). Objectives To study the 12-month effects of ECP on …
Treatment of patients with systemic sclerosis with extracorporeal photochemotherapy (photopheresis)
DNH Enomoto, JR Mekkes, PMM Bossuyt… - Journal of the American …, 1999 - Elsevier
Background: Effective treatment modalities for systemic sclerosis, a life-threatening and
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …
Photopheresis: advances and use in systemic sclerosis
Abstract Purpose of Review Extracorporeal photochemotherapy (photopheresis, ECP) is a
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …
cell-based immunomodulatory treatment that separates leukocytes from peripheral blood …
Extracorporeal photochemotherapy in progressive systemic sclerosis: a follow‐up study
J Schwartz, J Gonzalez, M Palangio… - International journal …, 1997 - Wiley Online Library
Background Extracorporeal photochemotherapy (photopheresis), an immune‐modulating
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …
Extracorporeal photochemotherapy in systemic sclerosis and severe morphea
B Cribier, T Faradji, C Le Coz, F Oberling, E Grosshans - Dermatology, 1995 - karger.com
Background: Extracorporeal photochemotherapy (EP) is a new immune-modulating therapy
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …
which combines cytapheresis and extracorporeal irradiation of leukocytes by UVA. Recently …
A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis
RM Knobler, LE French, Y Kim, E Bisaccia… - Journal of the American …, 2006 - Elsevier
BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …
marked involvement of the skin and joints for which few effective evidence based therapies …
Incidence of lung cancer in patients with systemic sclerosis treated with extracorporeal photopheresis
S Topuzoglu, R Knobler, O Movadat… - Photodermatology …, 2015 - Wiley Online Library
Background Extracorporeal photopheresis (ECP) improves skin sclerosis in systemic
sclerosis (SS c) patients. SSc is associated with an increased risk of lung cancer. As ECP is …
sclerosis (SS c) patients. SSc is associated with an increased risk of lung cancer. As ECP is …